Skip to content

Engaging Care for HIV-infected Adolescent Females.

Drug Use and HIV-Infected Female Adolescents' Care Use

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00489034
Enrollment
178
Registered
2007-06-21
Start date
2003-07-31
Completion date
2010-12-31
Last updated
2017-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infection

Keywords

HIV, adolescent females, adherence, clinical care, risk behaviors

Brief summary

The proposed multi-site, longitudinal study will examine the correlation of substance use, mental health disorders, and social networks to engagement in care for HIV-infected adolescent females, aged 13 years, 0 months - 23 years, 11 months, and suggest ways to promote adherence and retention in treatment, care, and prevention programs. Qualitative and quantitative data collection methods will be used with index participants and network members.

Detailed description

The primary outcome examined in the proposed study is engagement in care, operationalized as the number of clinical visits attended. Clinic visits will be monitored on a weekly basis. Secondary outcomes of interest include medication adherence, sexual risk behaviors, and substance use. For the quantitative study, formal psychological testing will be conducted with index adolescent females, and biological specimens will be collected to validate self-reported drug use. CD-4 counts and viral load will be monitored every three months via chart review. Index adolescents will be interviewed every six months (with phone interviews focused on service utilization at each six month interval midpoint) for eighteen months while network members will be interviewed at baseline and one year. Qualitative interviews in the Ethnographic Study will be conducted with a small sub-sample of index and identified network participants from each site at least monthly for a period of at least 18 months. Qualitative interviews will be ethnographic in nature and will rely on participants' life stories and narratives of social experience to supply their content and to guide their progression. Qualitative Interviews in the Gender Substudy will be conducted with a subsample of index participants. These qualitative interviews will focus on issues of gender related vulnerabilities and will be used to develop a survey to be administered to all index participants from sites participating in this substudy.

Interventions

BEHAVIORALQuantitative Interview

Index participants will be interviewed every six months (with phone interviews focused on service utilization at each six month interval midpoint) for 18 months while network members will be interviewed at baseline and one year. Interviews will consist of in-depth face-to-face and audio computer-assisted interviews (ACASIs) and a structured diagnostic interview to assess engagement in care (number of clinical visits attended), substance use, attitudes about substance use, friend's substance use, sexual risk behaviors, PTSD (for index participants only), support of index participants care use (network participants only), attitudes about healthcare (network participants only), index participant's adherence (network participants only), own functioning (network participants only), and family functioning (network participants only). At Baseline only, a urine sample will be collected from index participants for drug testing to assess the agreement between urine and ACASI.

Qualitative interviews will be conducted with a small sub-sample of index and identified network participants from each site at least monthly for a period of 18 months. Interviews will be ethnographic in nature and will rely on participants' life stories and narratives of social experience to supply their content and guide their progression.

BEHAVIORALGender Interview

Qualitative interviews will be conducted with a sub-sample of index participants. These interviews will focus on issues of gender related vulnerabilities and will be used to develop a survey.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
13 Years to 23 Years
Healthy volunteers
No

Inclusion criteria

Quantitative Study Inclusion Criteria Index Participants: 1. Female. 2. Age 13 years, 0 months - 23 years, 11 months (364 days). 3. All race/ethnicities. 4. English or Spanish speaking. 5. Non-perinatal, non-transfusion acquired HIV. 6. Unknown transmission status with study personnel approval. Network Participants: Parents/Guardians of Index Participants: 1. Know patient's HIV status 2. Male or female. 3. All race/ethnicities 4. English or Spanish speaking. 5. Serve a parental or guardian-like role. Close Friend of Index Participants: 1. Close friend of index subject. 2. Male or female. 3. Minimum age 13 years, 0 months. 4. All race/ethnicities 5. English or Spanish speaking Ethnographic Sub-Sample Inclusion Criteria: Index Participants: 1. Enrolled in Quantitative NIDA study. 2. English-speaking at Miami, New York, Chicago, and New Orleans sites. 3. English or Spanish-speaking at Los Angeles USC site Network Participants: 1. English-speaking at Miami, New York, Chicago, and New Orleans sites. 2. English or Spanish-speaking at Los Angeles USC site. 3. Know index serostatus. Gender Sub-Sample Inclusion Criteria: 1. Age 18 years, 0 months - 23 years, 11 months. 2. Enrolled in quantitative study. 3. English-speaking. 4. Female.

Design outcomes

Primary

MeasureTime frameDescription
Engagement in Care among Index ParticipantsBaseline, 6 months, 12 months, and 18 monthsEngagement in care will be operationalized as the number of clinic visits attended and will be assessed through the qualitative interviews.

Secondary

MeasureTime frameDescription
Substance UseBaseline, 6 months, 12 months, and 18 monthsAs assessed through the qualitative interviews for index and network participants.
Medication AdherenceBaseline, 6 months, 12 months, and 18 monthsAs assessed through the qualitative interviews for index and network participants.
Sexual Risk BehaviorsBaseline, 6 months, 12 months, and 18 monthsAs assessed through the qualitative interviews for index and network participants.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026